The Antibiotics Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
The global antibiotics market is anticipated to grow owing to the rise in the prevalence of infectious diseases. In addition, the demand is being fuelled by the emergence of innovative methods for new antibiotics for treating bacterial infections, as well as a large number of clinical trials. However, the industry is expected to be hampered by the rise of antibiotic resistance, which is fuelled by antibiotic abuse, as well as the time it takes for regulatory approval. On the other hand, market players across the value chain should expect major profit potential from the development of advanced prospect molecules & novel combination therapies to treat antibiotic-resistant microbial (AMR) infections.
The global antibiotics market is anticipated to grow owing to the rise in the prevalence of infectious diseases. In addition, the demand is being fuelled by the emergence of innovative methods for new antibiotics for treating bacterial infections, as well as a large number of clinical trials. However, the industry is expected to be hampered by the rise of antibiotic resistance, which is fuelled by antibiotic abuse, as well as the time it takes for regulatory approval. On the other hand, market players across the value chain should expect major profit potential from the development of advanced prospect molecules & novel combination therapies to treat antibiotic-resistant microbial (AMR) infections.
What Questions Should You Ask before Buying a Market Research Report?
- How is the antibiotics market evolving?
- What is driving and restraining the antibiotics market?
- How will each antibiotics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
- How will the market shares for each antibiotics submarket develop from 2023 to 2033?
- What will be the main driver for the overall market from 2023 to 2033?
- Will leading antibiotics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
- Who are the leading players and what are their prospects over the forecast period?
- What are the antibiotics projects for these leading companies?
- How will the industry evolve during the period between 2023 and 2033? What are the implications of
- Is there a greater need for product commercialisation to further scale the antibiotics market?
- Where is the antibiotics market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the antibiotics market today, and over the next 10 years:
- Our 388-page report provides 144 tables and 223 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them - NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
Forecasts to 2033 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2033, the new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.
Segments Covered in the Report
Action Mechanism
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
- Others
Drug Class
- Cephalosporin
- Penicillin
- Fluoroquinolone
- Macrolide
- Carbapenem
- Aminoglycoside
- Sulfonamide
- 7-ACA
- Others
Gender
- Male
- Female
Age Group
- 0-14 years
- 15-54 years
- 55 years and over
Route of Administration
- Oral
- Intravenous
- Others
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Denmark
- Norway
- Sweden
- Finland
- Netherlands
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- Singapore
- Malaysia
- Sri Lanka
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
MEA
- GCC
- South Africa
- Rest of MEA
Leading companies and the potential for market growth
- Abbott Laboratories
- Allergan (AbbVie Inc.)
- Amneal Pharmaceuticals LLC
- Cipla Ltd.
- Cumberland Pharmaceuticals, Inc.
- F. Hoffmann-La Roche Ltd.
- GSK plc
- Lupin
- Melinta Therapeutics LLC
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- Viatris, Inc.
- WOCKHARDT
How will the Antibiotics Market, 2023 to 2033 report help you?
In summary, this 380+ page report provides you with the following knowledge:- Revenue forecasts to 2033 for Antibiotics Market, 2023 to 2033 Market, with forecasts for Action Mechanism, Drug Class, Gender, Age Group, and Route of Administration, each forecast at a global and regional level - discover the industry’s prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2033 for five regional and 30 key national markets - See forecasts for the Antibiotics Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market - including company profiles for 16 of the major companies involved in the Antibiotics Market, 2023 to 2033.
Information found nowhere else
With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. The study is for everybody needing commercial analyses for the Antibiotics Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.Table of Contents
1 Report Overview
3 Market Overview
4 Antibiotics Market Analysis by Action Mechanism
5 Antibiotics Market Analysis by Drug Class
6 Antibiotics Market Analysis by Gender
7 Antibiotics Market Analysis by Age Group
8 Antibiotics Market Analysis by Route of Administration
9 Antibiotics Market Analysis by Region
10 North America Antibiotics Market Analysis
11 Europe Antibiotics Market Analysis
12 Asia Pacific Antibiotics Market Analysis
13 Latin America Antibiotics Market Analysis
14 MEA Antibiotics Market Analysis
15 Company Profiles
16 Conclusion and Recommendations
Companies Mentioned
- Abbott Laboratories
- Allergan (AbbVie Inc.)
- Amneal Pharmaceuticals LLC
- Cipla Ltd.
- Cumberland Pharmaceuticals, Inc.
- F. Hoffmann-La Roche Ltd.
- GSK plc
- Lupin
- Melinta Therapeutics LLC
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
- Teva Pharmaceutical Industries Ltd.
- Viatris, Inc.
- WOCKHARDT
- Acurx Pharmaceuticals, Inc.
- ADVANZ PHARMA Corp. Limited
- Alfresa Pharma Corporation
- Amplyx Pharmaceuticals
- BD
- Centrient Pharmaceuticals
- Cidara Therapeutics
- Daiichi Sankyo Company, Limited
- Dr. Reddy's Laboratories Ltd.
- Evonik
- Hikma Pharmaceuticals PLC
- Jiangxi Jemincare Group Company
- Kiora Pharmaceuticals, Inc.
- Medochemie
- Mutabilis
- Nosopharm
- NovoBiotic Pharmaceuticals, LLC
- Olgram SAS
- Paratek Pharmaceuticals, Inc.
- Phathom Pharmaceuticals, Inc.
- Sandoz
- Shionogi & Co., Ltd.
- Sistema Group
- Spero Therapeutics, Inc.
- Sumitomo Dainippon Pharma Co., Ltd
- Sumitovant Biopharma Ltd.
- Tabuk Pharmaceutical Manufacturing Company
- Venatorx Pharmaceuticals, Inc.
- Alliance for the Prudent Use of Antibiotics
- American Medical Association
- Antibiotic Research UK
- BEAM (Biotech companies in Europe combating Anti-Microbial Resistance) Alliance
- Centers for Disease Control and Prevention
- European Centre for Disease Prevention and Control (ECDC)
- European Medicines Agency (EMA)
- Food and Drug Administration (FDA)
- Global Antibiotic Research & Development Partnership (GARDP)
- Global Antimicrobial Resistance Surveillance System (GLASS)
- Infectious Diseases Society of America
- International Society of Antimicrobial Chemotherapy
- Journal of Medical Society
- Microbiology Society
- National Institute for Health and Clinical Excellence (NICE)
- National Institutes of Health (NIH)
- Society of Hospital Medicine
- The British Society for Antimicrobial Chemotherapy (BSAC)
- The Infectious Diseases Society of America (IDSA)
- World Health Organization (WHO)
